• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?肥胖会增加慢性乙型肝炎患者患肝细胞癌的风险吗？
Clin Mol Hepatol. 2016 Sep;22(3):336-338. doi: 10.3350/cmh.2016.0104. Epub 2016 Sep 25.
2
Comment on: Expressions of MiR-132 in patients with chronic hepatitis B, posthepatitic cirrhosis and hepatitis B virus-related hepatocellular carcinoma.关于《慢性乙型肝炎、肝炎后肝硬化及乙型肝炎病毒相关肝细胞癌患者中MiR-132的表达》的评论
Eur Rev Med Pharmacol Sci. 2019 Feb;23(4):1384-1385. doi: 10.26355/eurrev_201902_17093.
3
On-treatment predictors of hepatocellular carcinoma in patients with chronic hepatitis B.慢性乙型肝炎患者肝细胞癌的治疗期预测指标
Liver Int. 2021 Jul;41(7):1700-1701. doi: 10.1111/liv.14934. Epub 2021 May 24.
4
Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers.
Aliment Pharmacol Ther. 2017 Jan;45(1):185-186. doi: 10.1111/apt.13829.
5
Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma.
Aliment Pharmacol Ther. 2016 Jul;44(2):210-1. doi: 10.1111/apt.13674.
6
Letter: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance.
Aliment Pharmacol Ther. 2017 May;45(9):1286-1288. doi: 10.1111/apt.13983.
7
Response to: 'Prognosis of immune-tolerant phase chronic hepatitis B' by Chu and Liaw.对朱和廖的《免疫耐受期慢性乙型肝炎的预后》的回应
Gut. 2018 May;67(5):988-989. doi: 10.1136/gutjnl-2017-315815. Epub 2018 Jan 13.
8
Postoperative Antiviral Therapy With Nucleos(t)ide Analogs in Patients With Hepatitis B Virus--Related Hepatocellular Carcinoma.
Ann Surg. 2017 Apr;265(4):e46-e47. doi: 10.1097/SLA.0000000000001224.
9
T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.框α中的T1653突变增加了慢性乙型肝炎病毒C基因型感染患者患肝细胞癌的风险。
Clin Infect Dis. 2006 Jan 1;42(1):1-7. doi: 10.1086/498522. Epub 2005 Nov 29.
10
Letter: should anti-viral therapy be recommended for individuals chronically infected with hepatitis B virus and at low risk of hepatocellular carcinoma? Authors' reply.信件：对于慢性感染乙型肝炎病毒且肝细胞癌风险较低的个体，是否应推荐抗病毒治疗？作者回复。
Aliment Pharmacol Ther. 2017 Jan;45(1):182-183. doi: 10.1111/apt.13849.

本文引用的文献

1
Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B.荟萃分析：口服抗病毒药物对慢性乙型肝炎患者肝细胞癌发生率的影响。
Aliment Pharmacol Ther. 2013 Jul;38(2):98-106. doi: 10.1111/apt.12344. Epub 2013 May 28.
2
Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection.长期恩替卡韦治疗可降低乙型肝炎病毒感染患者肝细胞癌的发生率。
Hepatology. 2013 Jul;58(1):98-107. doi: 10.1002/hep.26180. Epub 2013 Mar 6.
3
Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.基于系统综述的非酒精性脂肪性肝病与肝细胞癌风险的相关性。
Clin Gastroenterol Hepatol. 2012 Dec;10(12):1342-1359.e2. doi: 10.1016/j.cgh.2012.10.001. Epub 2012 Oct 4.
4
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.欧洲肝脏研究学会-欧洲肿瘤内科学会临床实践指南：肝细胞癌的管理
J Hepatol. 2012 Apr;56(4):908-43. doi: 10.1016/j.jhep.2011.12.001.
5
Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis.糖尿病与肝细胞癌风险：系统评价和荟萃分析。
Diabetes Metab Res Rev. 2012 Feb;28(2):109-22. doi: 10.1002/dmrr.1291.
6
Hepatic complications of obesity.肥胖相关的肝脏并发症。
Gastroenterol Clin North Am. 2010 Mar;39(1):57-68. doi: 10.1016/j.gtc.2009.12.001.
7
Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma.荟萃分析：乙型肝炎感染的治疗可降低肝细胞癌风险。
Aliment Pharmacol Ther. 2008 Nov 1;28(9):1067-77. doi: 10.1111/j.1365-2036.2008.03816.x. Epub 2008 Jul 24.
8
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.代谢因素与慢性乙型/丙型肝炎感染导致肝细胞癌的风险：台湾的一项随访研究
Gastroenterology. 2008 Jul;135(1):111-21. doi: 10.1053/j.gastro.2008.03.073. Epub 2008 Apr 4.
9
Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors.慢性乙型肝炎的自然史：特别关注疾病进展和预后因素。
J Hepatol. 2008 Feb;48(2):335-52. doi: 10.1016/j.jhep.2007.11.011. Epub 2007 Dec 4.
10
Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies.超重、肥胖与肝癌风险：队列研究的荟萃分析
Br J Cancer. 2007 Oct 8;97(7):1005-8. doi: 10.1038/sj.bjc.6603932. Epub 2007 Aug 14.

Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?

作者信息

Jang Byoung Kuk

机构信息

Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea.

出版信息

Clin Mol Hepatol. 2016 Sep;22(3):336-338. doi: 10.3350/cmh.2016.0104. Epub 2016 Sep 25.

DOI:10.3350/cmh.2016.0104
PMID:27729635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5066385/
Abstract
摘要